Inflammatory Bowel Disease (IBD): Diagnosis and Personalized Treatment
A special issue of Journal of Personalized Medicine (ISSN 2075-4426). This special issue belongs to the section "Personalized Therapy and Drug Delivery".
Deadline for manuscript submissions: 25 December 2025 | Viewed by 97
Special Issue Editor
2. Division of Gastroenterology & Liver Diseases, School of Medicine, Case Western Reserve University, Cleveland, OH 44106, USA
3. Digestive Health Research Institute, University Hospitals Cleveland Medical Center, Cleveland, OH 44106, USA
Interests: inflammatory bowel diseases (IBD); clinical nutrition; nutrigenomics; gastroenterology
Special Issue Information
Dear Colleagues,
Inflammatory Bowel Disease (IBD) is a complex, relapsing, and immune-mediated disorder of the gut that is characterized by significant variability in disease presentation, progression, and treatment response. Despite advances in IBD therapies, the heterogeneity of the disease poses a major challenge in achieving optimal patient outcomes, as many patients experience primary non-response or loss of response to treatment. Today, the "one-size-fits-all" approach to IBD management is being increasingly replaced by precision medicine strategies that tailor diagnosis and therapy based on individual patient characteristics, including genetics, microbiome composition, immune profiling, and environmental factors.
The Journal of Personalized Medicine invites submissions to this Special Issue, which focuses on the latest advancements in the diagnosis and personalized treatment of IBD. This Special Issue aims to explore innovative diagnostic tools, biomarkers, and therapeutic strategies tailored to individual patient profiles, enhancing the precision and efficacy of IBD management.
We welcome the submission of original research articles, reviews, and clinical studies that address the molecular mechanisms, genetic predispositions, and environmental factors influencing IBD. Topics of interest for this Special Issue include, but are not limited to, the following:
- Novel diagnostic biomarkers and imaging techniques;
- Genetic and epigenetic profiling in IBD;
- Personalized pharmacotherapy and biologics;
- Microbiome-based interventions;
- Multi-Omics approaches;
- Artificial intelligence;
- Patient-reported outcomes and quality of life in personalized treatment.
This Special Issue seeks to provide a comprehensive overview of the current state and future directions in personalized medicine for IBD, fostering a deeper understanding and improved clinical outcomes for patients worldwide.
Dr. Abigail Raffner (formerly Basson)
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Personalized Medicine is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- inflammatory bowel disease
- diagnostic tools
- biomarkers
- therapeutic strategies
- molecular mechanisms
- microbiome
- genetic predispositions
- environmental factors
- personalized treatment
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue policies can be found here.
